Because standard gastrointestinal absorption of B12 is highly complex and easily disrupted by age, low stomach acid, medications, and chronic inflammation, therapeutic dosing often needs to be significantly higher than the standard Recommended Daily Allowance (RDA) of 2.4 mcg
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
It is less about replacing nutrition and more about giving the body targeted support directly
The resulting liquid should be clear and free of particles
doi: 10.1038/s41577-021-00652-6 96 JamesJ
A practice administering 2,000 vaccines annually feels the impact of even a $1 per-unit underpayment
